Results 231 to 240 of about 1,479,789 (367)

Cigarette smoking and nasopharyngeal carcinoma

open access: bronze, 1985
Kiyóhiko Mabuchi   +2 more
openalex   +1 more source

Association between microsatellites within the human MHC and nasopharyngeal carcinoma [PDF]

open access: bronze, 1997
Eng Eong Ooi, Ee Chee Ren, Soh Ha Chan
openalex   +1 more source

Should We Advance Our Understanding of Immunoglobulin E in Viral Immunity?

open access: yesImmunology, Volume 176, Issue 3, Page 312-321, November 2025.
Immunoglobulin E has been extensively studied in allergies and parasitic diseases. Antigen‐specific IgE has been identified as part of the humoral response to viruses. This revision speculates on possible functionalities for IgE, such as neutralisation, cytotoxicity and immunopathology of viral diseases, and provide insights about gaps to fill in ...
Amanda Izeli Portilho   +3 more
wiley   +1 more source

Ototoxicity in Cancer Therapies

open access: yes
Oral Diseases, EarlyView.
Sady Selaimen da Costa   +2 more
wiley   +1 more source

A Single Institution Retrospective Comparison of Two Radiotherapy Protocols for the Palliative Treatment of Canine Nasal Carcinoma

open access: yesVeterinary Radiology &Ultrasound, Volume 66, Issue 6, November 2025.
ABSTRACT Optimal radiation protocols for canine nasal carcinoma are not established. Co‐morbidities, access, and owner compliance can influence scheduling. Between 2015 and 2022, two radiotherapy protocols were used in the palliative treatment of canine nasal carcinoma at a single institution.
Alison Hayes   +3 more
wiley   +1 more source

Multimodal AI-based risk stratification for distant metastasis in nasopharyngeal carcinoma. [PDF]

open access: yesESMO Open
Zhou J   +11 more
europepmc   +1 more source

Apoptosis regulators of the Bcl‐2 family play a key role in chemoresistance of cholangiocarcinoma organoids

open access: yesInternational Journal of Cancer, Volume 157, Issue 8, Page 1694-1708, 15 October 2025.
What's New? Poor prognosis in cholangiocarcinoma (CCA) is attributed to late diagnosis and intrinsic chemoresistance. In particular, resistance mechanisms that suppress apoptosis limit the effectiveness of gemcitabine‐based regimens, which remain the standard treatment.
Wunan Mi   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy